Application 072695
- Type
- ANDA
- Sponsor
- BARR
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NORTREL 0.5/35-28 | ETHINYL ESTRADIOL; NORETHINDRONE | TABLET;ORAL-28 | 0.035MG;0.5MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A072695-001 | NORTREL 0.5/35-28 | ETHINYL ESTRADIOL; NORETHINDRONE | 0.035MG;0.5MG | TABLET / ORAL-28 | AB | 1992-02-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A072695-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A072695-001 | NORTREL 0.5/35-28 | 0.035MG;0.5MG | TABLET / ORAL-28 | AB | 1992-02-28 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A072695-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nortrel 28 Day | NORETHINDRONE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 33b895e4-b467-41b1-a812-8068cc5bb93e | 2024-05-07 | Boxed warning, Warnings, Adverse reactions | 072695 ANDA072695 50090-3229 |
| Nortrel 28 Day | NORETHINDRONE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | 140c50d6-c931-423a-9aa0-526eae7ab93c | 2021-12-01 | Boxed warning, Warnings, Adverse reactions | 072695 ANDA072695 0555-9008 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0555-9008 | Nortrel | Norethindrone and Ethinyl Estradiol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0555-9008 | Nortrel | Norethindrone and Ethinyl Estradiol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0555-9008 | Nortrel | Norethindrone and Ethinyl Estradiol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0555-9008 | Nortrel | Norethindrone and Ethinyl Estradiol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0555-9008 | Nortrel | Norethindrone and Ethinyl Estradiol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0555-9008 | Nortrel | Norethindrone and Ethinyl Estradiol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 50090-3229 | Nortrel | Norethindrone and Ethinyl Estradiol | A-S Medication Solutions | ANDA | Current |
| 51862-318 | Necon | Norethindrone and Ethinyl Estradiol | Mayne Pharma Inc. | ANDA | Current |
| 51862-318 | Necon | Norethindrone and Ethinyl Estradiol | Mayne Pharma Inc. | ANDA | Current |
| 51862-318 | Necon | Norethindrone and Ethinyl Estradiol | Mayne Pharma Inc. | ANDA | Current |